English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/183946
logo share SHARE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE
Exportar a otros formatos:


Nanomaterials for combined thermo-chemotherapy of cancer

AuthorsIdiago López, Francisco Javier; Moreno Antolín, Eduardo ; Fratila, Raluca M.
Cancer treatment
Carbon-based nanomaterials
Gold nanoparticles
Magnetic nanoparticles
Synergistic effect
Issue Date2019
CitationNanomaterials for Magnetic and Optical Hyperthermia Applications: 287-314 (2019)
SeriesMicro and Nano Technologies
AbstractDespite significant advances during the last decades, chemotherapy still suffers from important drawbacks such as severe side effects, insufficient drug availability in the tumor tissue, and multidrug resistance. Thermal sensitization can potentiate the effect of chemotherapy, resulting in a more efficient cancer treatment. In this regard, the combined approach of hyperthermia and nanomaterials is especially promising, as nanotechnology offers the possibility to construct multifunctional nanoplatforms for active targeting, drug delivery, and therapy. In this chapter, we discuss several examples from the recent literature on the use of magnetic and plasmonic (gold and carbon-based) nanomaterials for thermo-chemotherapy, highlighting the synergistic effects of the combined approach. We conclude with a short discussion on the future challenges in the field in order to address the translational aspects of this new potential therapeutic solution.
Publisher version (URL)https://doi.org/10.1016/B978-0-12-813928-8.00011-9
Identifiersdoi: 10.1016/B978-0-12-813928-8.00011-9
isbn: 978-0-12-813928-8
Appears in Collections:(ICMA) Libros y partes de libros
Files in This Item:
File Description SizeFormat 
CL6-nanomaterial.pdf1,44 MBAdobe PDFThumbnail
Show full item record
Review this work

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.